Impact of molecular subtype and race on HR+, HER2- breast cancer survival.

Sonya A ReidDiane HaddadAnn TezakAnne WeidnerXuefeng WangBrian MautzJaleesa MooreSydney CadizYuwei ZhuWei ZhengIngrid A MayerXiao-Ou ShuTuya Pal

Published in: Breast cancer research and treatment (2021)

Molecular subtype classification highlights racial disparities in PAM50 subtype distribution among women with HR+, HER2- breast cancer. Among women with HR+, HER2- breast cancer, racial survival disparities are ameliorated after adjusting for molecular subtype.

Keyphrases

machine learning
single molecule
deep learning
african american
healthcare
free survival
breast cancer risk